BRS3

bombesin receptor subtype 3, the group of Bombesin receptors

Basic information

Region (hg38): X:136487946-136493780

Links

ENSG00000102239 ∙ NCBI:680 ∙ OMIM:300107 ∙ HGNC:1113 ∙ Uniprot:P32247 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the BRS3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the BRS3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous				1		1
missense			15	2		17
nonsense			1			1
start loss						0
frameshift						0
inframe indel						0
splice donor/acceptor (+/-2bp)						0
splice region						0
non coding						0
Total	0	0	16	3	0

Variants in BRS3

This is a list of pathogenic ClinVar variants found in the BRS3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
X-136488136-T-C		not specified	Uncertain significance (May 11, 2022)
X-136488202-G-A		not specified	Uncertain significance (Sep 16, 2021)
X-136488229-G-A		not specified	Uncertain significance (Feb 22, 2023)
X-136488233-A-G		not specified	Uncertain significance (Jan 31, 2024)
X-136488400-C-T		not specified	Uncertain significance (Nov 08, 2021)
X-136488488-T-G		not specified	Uncertain significance (Mar 20, 2024)
X-136490161-C-T			Uncertain significance (Oct 08, 2021)
X-136490165-A-G		not specified	Uncertain significance (Jun 06, 2023)
X-136490209-G-A			Likely benign (Nov 01, 2022)
X-136490230-T-G		not specified	Uncertain significance (Jan 04, 2022)
X-136490248-A-G		not specified	Uncertain significance (May 02, 2024)
X-136490282-A-G		not specified	Uncertain significance (Jun 10, 2022)
X-136490345-T-C		not specified	Uncertain significance (Feb 12, 2024)
X-136490368-G-T		not specified	Uncertain significance (Apr 22, 2022)
X-136490369-T-G		not specified	Uncertain significance (Feb 06, 2024)
X-136491976-G-T		not specified	Uncertain significance (Apr 16, 2024)
X-136491991-G-A			Likely benign (Apr 01, 2022)
X-136492073-A-G		not specified	Uncertain significance (Dec 13, 2023)
X-136492147-C-G		not specified	Uncertain significance (Feb 27, 2024)
X-136492207-G-T		not specified	Uncertain significance (Jun 24, 2022)
X-136492218-G-C		not specified	Uncertain significance (May 25, 2022)
X-136492237-G-C		not specified	Likely benign (Nov 03, 2022)

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
BRS3	protein_coding	protein_coding	ENST00000370648	3	5894

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
0.948	0.0514	125539	1	0	125540	0.00000398

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	0.939	117	149	0.784	0.0000109	2591
Missense in Polyphen		33	62.234	0.53025		1132
Synonymous	-0.274	62	59.3	1.05	0.00000455	834
Loss of Function	2.83	0	9.35	0.00	7.55e-7	162

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.00	0.00
Ashkenazi Jewish	0.00	0.00
East Asian	0.00	0.00
Finnish	0.00	0.00
European (Non-Finnish)	0.00	0.00
Middle Eastern	0.00	0.00
South Asian	0.0000524	0.0000327
Other	0.00	0.00

dbNSFP

Source: dbNSFP

• Function: FUNCTION: Role in sperm cell division, maturation, or function. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.
• Pathway: Neuroactive ligand-receptor interaction - Homo sapiens (human);Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

• pRec: 0.0878

Intolerance Scores

• rvis_EVS: -0.36
• rvis_percentile_EVS: 28.63

Haploinsufficiency Scores

• pHI: 0.368
• hipred: Y
• hipred_score: 0.738
• ghis: 0.452

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: N
• gene_indispensability_score: 0.114

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Brs3
• Phenotype: adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan)

Gene ontology

• Biological process: glucose metabolic process;G protein-coupled receptor signaling pathway;regulation of blood pressure;adult feeding behavior;bombesin receptor signaling pathway
• Cellular component: plasma membrane;integral component of plasma membrane;integral component of membrane;neuron projection;neuronal cell body
• Molecular function: G protein-coupled receptor activity;bombesin receptor activity